Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients.
Correale P, Cusi MG, Tsang KY, Del Vecchio MT, Marsili S, Placa ML, Intrivici C, Aquino A, Micheli L, Nencini C, Ferrari F, Giorgi G, Bonmassar E, Francini G. Correale P, et al. Among authors: bonmassar e. J Clin Oncol. 2005 Dec 10;23(35):8950-8. doi: 10.1200/JCO.2005.12.147. Epub 2005 Aug 1. J Clin Oncol. 2005. PMID: 16061910 Clinical Trial.
Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro.
Correale P, Aquino A, Giuliani A, Pellegrini M, Micheli L, Cusi MG, Nencini C, Petrioli R, Prete SP, De Vecchis L, Turriziani M, Giorgi G, Bonmassar E, Francini G. Correale P, et al. Among authors: bonmassar e. Int J Cancer. 2003 Apr 20;104(4):437-45. doi: 10.1002/ijc.10969. Int J Cancer. 2003. PMID: 12584740 Free article.
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro.
Correale P, Cusi MG, Del Vecchio MT, Aquino A, Prete SP, Tsang KY, Micheli L, Nencini C, La Placa M, Montagnani F, Terrosi C, Caraglia M, Formica V, Giorgi G, Bonmassar E, Francini G. Correale P, et al. Among authors: bonmassar e. J Immunol. 2005 Jul 15;175(2):820-8. doi: 10.4049/jimmunol.175.2.820. J Immunol. 2005. PMID: 16002679 Free article.
Circulating tumor cells in colorectal cancer patients.
Torino F, Bonmassar E, Bonmassar L, De Vecchis L, Barnabei A, Zuppi C, Capoluongo E, Aquino A. Torino F, et al. Among authors: bonmassar e, bonmassar l. Cancer Treat Rev. 2013 Nov;39(7):759-72. doi: 10.1016/j.ctrv.2012.12.007. Epub 2013 Jan 30. Cancer Treat Rev. 2013. PMID: 23375250 Review.
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies.
Bonmassar L, Fossile E, Scoppola A, Graziani G, Prete SP, Formica V, Cappelletti D, De Vecchis L, Cardillo A, Concolino F, D'Atri S, Balduzzi A, Torino F, Caporaso P, Greiner JW, Bonmassar E, Roselli M, Aquino A. Bonmassar L, et al. Among authors: bonmassar e. Anticancer Res. 2010 Nov;30(11):4721-30. Anticancer Res. 2010. PMID: 21115931
258 results